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Aim To gain deeper insight into the seroprevalence of bru-
cellosis, which remains a zoonotic disease of worldwide 
public health concern, by reviewing studies from countries 
including North Africa, the Middle East, and India.
Methods Studies on brucellosis performed in countries 
that are neighbors or important trading partners of the 
European Union and on trade animals and their products 
were analyzed. We reviewed 37 seroprevalence studies on 
brucellosis published from 1948 to 2009 retrieved from 
Pubmed, Google, and ScienceDirect.
Results The set of studies was heterogeneous in the num-
ber of samples and laboratory tests used. We included 
studies from Algeria (n = 1), Egypt (n = 7), India (n = 3), Iran 
(n = 3), Iraq (n = 1), Jordan (n = 5), Libya (n = 3), Saudi Arabia 
(n = 3), Syria (n = 1), Turkey (n = 5), and Yemen (n = 2). The 
total number of animals in these studies was 116 317 (cat-
tle 75 375; buffalo 9644; sheep 10 550; goats 14 447; cam-
els 6301). The prevalence of brucellosis in different animal 
species varied widely. Representative surveillance data 
have not recently been published in any of the countries.
Conclusions Wars in the Middle East, insufficient preven-
tive measures, the lack of adequate control programs in 
some countries, as well as uncontrolled animal transporta-
tion through “open” borders increased the risk that brucel-
losis will spread in some regions. New seroprevalence data 
are needed urgently to evaluate the current situation and 
for continuous monitoring of necessary control programs.
Mayada Gwida1,2, Sascha 
Al Dahouk3, Falk Melzer1, 
Uwe Rösler4, Heinrich 
Neubauer1, Herbert 
Tomaso1
1Friedrich-Loeffler-Institut, 
Institute of Bacterial Infections and 
Zoonoses, Jena, Germany
2Department of Hygiene and 
Zoonoses, Faculty of Veterinary 
Medicine, Mansoura University, 
Mansoura, Egypt
3RWTH Aachen University, 
Department of Internal Medicine III, 
Aachen, Germany
4Freie Universität Berlin, Institut 
für Tier- und Umwelthygiene, 
Fachbereich Veterinärmedizin, 
Berlin, Germany
Received: February 15, 2010
Accepted: July 17, 2010
Correspondence to:  
Herbert Tomaso  
Friedrich-Loeffler-Institut  
Federal Research Institute for 
Animal Health  
Institute for Bacterial Infections and 
Zoonoses  
Naumburger Str. 96a  
07743 Jena, Germany 
herbert.tomaso@fli.bund.de
Brucellosis – Regionally 
Emerging Zoonotic Disease?
FORUM  
 
doi: 10.3325/cmj.2010.51.289
FORUM290 Croat Med J. 2010; 51: 289-95
www.cmj.hr
Brucellosis is one of the most important worldwide zoo-
noses affecting livestock and humans (1). Brucellae are 
facultative intracellular, Gram-negative coccobacilli that 
lack capsules, flagelle, and endospores. The genus Brucella 
comprises a group of closely related bacteria. The species 
B. melitensis (which infects sheep and goats), B. suis (swine), 
and B. abortus (cattle) cause significant economic losses for 
animal owners and severe human disease. Brucella spp. are 
also a focus of interest as they are categorized as biological 
agents due to their high contagiousness and their impact 
on human and animal health. The zoonotic pathogens B. 
abortus, B. melitensis, and B. suis were designated as select 
agents of Category B by the Centres for Disease Control in 
Atlanta, USA. This review analyzes studies from North Af-
rica, the Middle East, and India to gain a clear picture of our 
current understanding of brucellosis and assess threats to 
transmission into the European Union (EU). The review also 
identifies areas where research is sorely needed to ensure 
that brucellosis epidemics are avoided in the future.
TRANSMiSSioN
Human brucellosis is transmitted by inhalation, animal 
contact, and consumption of unpasteurized dairy prod-
ucts and undercooked meat products. For example, con-
sumption of traditional delicacies such as raw liver can 
cause human infection (2). In female animals, the bacte-
rium is localized in the tissues of the udder and is then ex-
creted via milk. In male animals, orchitis and epididymitis 
can lead to temporary or permanent infertility (3). Brucel-
la spp. can survive for long periods in dust, dung, water, 
slurry, aborted fetuses, soil, meat, and dairy products. As 
the infectious dose is very low, infections are an occupa-
tional risk for farmers, veterinarians, abattoir workers, labo-
ratory personnel, and others who work with animals and 
consume their products (4). The increase in business and 
leisure travel to brucellosis-endemic countries has led to 
importation of the disease into non-endemic areas (3). The 
prevalence of brucellosis in humans depends upon several 
factors such as dietary habits, methods of processing milk 
and milk products, husbandry practices, and environmen-
tal hygiene.
DiAGNoSiS
The “gold standard” in the diagnosis of brucellosis is bacte-
rial isolation, which requires long cultivation periods and 
is often unsuccessful. Although several polymerase chain 
reaction assays have been developed, serological tests 
are still frequently used as diagnostic methods. The 
most commonly used serological screening tests are the 
serum agglutination test (SAT), Rose Bengal test, comple-
ment fixation test, and enzyme-linked immunosorbent as-
say (5). All tests have limitations concerning specificity and 
sensitivity, especially when testing individual animals. The 
SAT appears less sensitive and less specific than any other 
standard test for all animal species compared (6). Thus, the 
SAT is no longer recommended as an official screening test 
for brucellosis within the European Union (7).
EpiDEMioloGy
Brucellosis causes more than 500 000 human infections 
per year worldwide. The disease has a limited geographic 
distribution, but it remains a major public health problem 
in the Mediterranean region, western Asia, parts of Africa 
and Latin America. Brucellosis in animals causes tremen-
dous economic losses due to abortion, premature birth, 
decreased milk production, and reduced reproduction 
rate. Despite the advances made in surveillance and con-
trol, the prevalence of brucellosis is increasing in many de-
veloping countries due to various sanitary, socioeconomic, 
and political factors (8). Brucellosis in cattle seems to be 
associated primarily with poor farm hygiene, unrestricted 
trade and movement of animals, use of local cattle yards 
and fairs for trading, the practice of returning non-lactating 
animals to villages for seasonal maintenance, and the use 
of semen from infected bulls of unknown health status for 
artificial insemination.
To review the literature on brucellosis seroprevalence, 
we retrieved studies published between 1948 and 2009 
about brucellosis in cattle, buffaloes, camels, sheep, and 
goats. The studies were retrieved using Pubmed (http://
www.ncbi.nlm.nih.gov/pubmed/), Google (http://www.
google.com), and ScienceDirect (http://www.siencedi-
rect). This search was focused on countries in a belt span-
ning from North Africa to India. These countries are neigh-
bors or important trading partners of the European Union 
and trade animals and their products among themselves. 
Table 1 and Table 2 list serological data provided by stud-
ies in selected countries.
The studies we retrieved were heterogeneous, especial-
ly in the number of samples and laboratory tests. Thus, a 
meta-analysis or comparison of these data sets is impos-
sible. Nevertheless, all of the studies together indicate that 
the prevalence of brucellosis in different animal species in 
Mediterranean countries, the Middle East, and India varies 
widely. High prevalence appears to be due to insufficient 
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preventive measures and the lack of adequate control pro-
grams in some countries, as well as uncontrolled animal 
transportation across “open” borders. Due to armed con-
flicts and political instability in various countries, it is very 
likely that previously successful eradication programs have 
had no lasting effect and brucellosis has become a se-
vere hygiene problem again. Therefore, there is an urgent 
need for the strict implementation of brucellosis eradica-
tion programs for cattle and small ruminants in affected re-
gions. Given the huge economic and medical impact such 
control policies are cost-effective (16).
The impact of control programs and the consequence of 
their subsequent neglect can be demonstrated by the sit-
uation in Iran. The prevalence of animal brucellosis in Iran 
reached 44% in 1956 and decreased to only 5% following 
a control program starting in 1958. Because control mea-
sures became lax, the prevalence increased to 17.4% in 
1977. A new control program was established in 1983 and 
the prevalence decreased again to 1.25% in 1987 and to 
0.85% in 1991. Nevertheless, the number of human cases of 
brucellosis recorded in 1988 was 710 521 (132.4/100,000), 
suggesting that the low animal prevalence reported was 
not representative for the total animal population (45). 
More recent country-wide data are not available.
In Iraq, several studies on the seroprevalence of brucellosis 
have been conducted in the recent decades. The Northern 
provinces of Iraq share an extensive border with Iran, Tur-
key, and Syria. Other provinces of Iraq share borders with 
Jordan, Saudi Arabia, and Kuwait. This geographic situa-
tion highlights the need for a strategic planning of con-
trol measures. In fact, due to its geographical location, the 
prevalence of brucellosis in Jordan may be an indicator of 
the status of the disease in neighboring countries in the 
Middle East region (17). In many countries there is a lack 
TAblE 1. brucellosis prevalence in cattle and buffaloes based on a survey of studies published between 1948 and 2009*
 
Species/country
 
year
Number of 
animals tested
Number of 
positive animals (%)
Diagnostic 
test
 
References
Cattle
Algeria 2006   1032  9.7 BPAT (9)
 8.2 RBPT
Egypt 2007   1966  5.4 BPAT (10)
India 1998 23 284  1.9 SAT (11)
2000    110  1.81 Culture (12)
2007    150 20.7 ELISA (13)
Iran 1990   6472  3.9 MRT (14)
2002-2006  12 113  6.8 RBPT (15)
Jordan 1973   1064  0.0 MRT (16)
1977    250  0.4 MRT (16)
2009    671 10.1 RBPT (17)
2009    671 10.1 ELISA
Libya 1985   3753  0.3 RBPT (18)
1986   8607  1. 5 SAT (19)
 1.8 CFT
Syria 1989 12 554  2.9 RBPT, CFT (20)
Turkey 2004-2006    407 32.9 RBPT (21)
2001-2006    626 35.3 RBPT (22)
39.5 ELISA
Yemen 1992-1993   1645  0.1 ELISA (23)
buffaloes
Egypt 2007    916  1.1 RBPT (24)
2007   1337  3.5 RBPT (10)
India 1998   7153  1.8 SAT (11)
2000    43  0.0 Culture (12)
2007    195 16.4 ELISA (13)
*Abbreviations: bpAT – buffered acidified plate agglutination test; RbpT– Rose bengal plate test; CFT – complement fixation test; SAT – standard 
tube agglutination test; RiV – Rivanol test; EliSA – enzyme linked immunosorbant assay; MRT – milk ring test; bCT – brewer card test.
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of recent data about the seroprevalence of brucellosis and 
further studies are required to assess the epidemiological 
situation.
The prevalence of brucellosis in animal reservoirs is the key 
to its control in humans. Eradication programs for bovine 
brucellosis markedly reduce the incidence in humans (46). 
TAblE 2. brucellosis in sheep, goats, and camels*
Species/country years
Number of 
animals tested
Number of 
positive animals (%) Diagnostic test References
Sheep
Egypt 2007   32 31.3 SAT (25)
25.6 RBPT
2007  813  5.4 BPAT (10)
Iraq 1979 2368  0.9 BCT (26)
India 2000  163  2. 5 Culture (12)
Jordan 1992  206 16.5 Culture (27)
2003  602 14.3 RBPT (28)
 7.2 ELISA
Syria 1989 1827  1.8 RBPT, CFT (20)
Turkey 2002-2004   37 38.0 Culture (29)
2007  167 40.1 SAT (30)
2008  400 36.7 SAT (31)
 400 35.5 RIV
 400 34.8 RBPT
 400 33.8 CFT
Yemen 1985  690  0.6 RBPT (32)
1992-1993 2045  0.6 ELISA (23)
Goats
Egypt 2007   33  3.5 BPAT (33)
India 2000  115  2.6 Culture (12)
2004   54 59.0 Serological test (34)
2004   54 88.8 PCR
Iraq 1979 3156  4.4 BCT (27)
2007  184 of which: RBPT (35)
  25 vaccinated 72.0
  17 aborted 52.9
 142 unvaccinated 20.4
Jordan 2001-2003 1100 27.7 RBPT (36)
Iran 2002-2006 7199  3.4 RBPT (15)
Yemen 1985  538  0.4 RBPT (32)
1992-1993 2014  1.3 ELISA (23)
Camels
Egypt 1948  200 20.0 SAT (37)
1993  360 11.6 SAT (38)
2004  766  8.7 RBPT (39)
Iran 2007 1123 10.5 RBPT (40)
 8.5 MRT
Libya 1993  967  4.1 RBPT (41)
Saudi Arabia 1987  146  1.4 RBPT (42)
1992 2536  8.0 RBPT (43)
1999-2000   98  7.1 RBPT (44)
Yemen 1992-1993  105  0.0 ELISA (23)
*Abbreviations: bpAT – buffered acidified plate agglutination test; RbpT– Rose bengal plate test; CFT – complement fixation test; SAT – standard 
tube agglutination test; RiV – Rivanol test; EliSA – enzyme linked immunosorbant assay; MRT – milk ring test; bCT – brewer card test.
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Worldwide reported incidence of human brucellosis in en-
demic areas varies widely, from <0.01 to >200 per 100 000 
inhabitants. However, the true incidence of human brucel-
losis is unknown due to misdiagnosis, underreporting, lack 
of proper laboratory facilities in remote areas, as well as 
poor cooperation and exchange of information between 
veterinary and public health services (47).
CoNTRol MEASURES
The initial aim of surveillance and control programs is the 
reduction of infection in the animal populations to reduce 
the effect of the disease on animal health and production, 
thus minimizing its impact on human health. Within the 
European Union, measures for the eradication of brucello-
sis are contained in Directive 2003/99/EC of the European 
Parliament. The epidemiological situation in its neighbor-
ing regions is of great importance for the EU due to the 
potential risk of importation of infected animals or their 
products (48).
An effective control of animal brucellosis requires the fol-
lowing elements: 1) surveillance to identify infected ani-
mal herds, 2) prevention of transmission to non-infected 
animal herds, and 3) eradication of the reservoir to elim-
inate the sources of infection in order to protect vulner-
able animals or herds coupled with measures to prevent 
re-introduction of the disease. In areas where a brucellosis-
free status has been established or where such a status is 
assumed from epidemiological data, the risk of importing 
the disease by means of animal movement must be elimi-
nated. Movement of infected animals must be prohibited 
and import permissions should be given only to certified 
brucellosis-free farms or areas. This is also true for national 
and international transport of animal products, in accor-
dance with the general principles and procedures speci-
fied in the International Zoo-Sanitary Code of the OIE (49). 
This code also describes the testing procedures for animals 
and quarantine measures. Control programs should take 
into account incidental spreading of brucellosis by infect-
ed but serologically negative animals originating from in-
adequately certified sources.
Vaccination of animals practically eliminates the clinical 
signs of brucellosis and reduces the likelihood that expo-
sure to the infectious agent will cause disease in humans. 
In small ruminants the initial step in brucellosis control is to 
vaccinate young animals (kept as replacements) with the 
B. melitensis Rev.1 vaccine. This approach is based on the 
hypothesis that the Rev.1 vaccine offers life-long immunity 
and that after implementing the vaccination program for 
5-7 years, which is the reproductive life-span of sheep and 
goats, the whole population will be vaccinated and fully 
protected against brucellosis. This method is also recom-
mended to minimize postvaccinal diagnostic problems 
and to prevent abortion (50).
The B. melitensis Rev.1 vaccine for small ruminants has not 
been fully evaluated for use in cattle. B. abortus vaccines do 
not effectively protect against B. melitensis infection, mean-
ing that bovine B. melitensis infections may pose a serious 
problem even for vaccinated cattle. In India, culling of cows 
is a taboo which also complicates eradication efforts.
iMpliCATioNS FoR THE FUTURE
There is a clear need for new studies on the seroprevalence 
of brucellosis in animals in many countries, as the pub-
lished studies are scarce, some are more than 20 years old, 
and they use different laboratory tests, making the data 
sets impossible to compare. Only the initiation of continu-
ous monitoring programs will allow an evaluation of the 
current status of brucellosis seroprevalence and the effec-
tiveness of control measures.
In addition, it will be nearly impossible to control this im-
portant zoonosis without reimbursement of farmers for 
their financial losses due to removal of infected animals as 
part of an effective herd and individual animal registration 
system. Farmers, the dairy industry, breeding companies, 
consumers, veterinarians, and politicians in each country 
must work together to find a suitable eradication strategy. 
Trade across borders will perpetuate the epizootic unless 
countries in the same region of the world coordinate their 
control and eradication programs.
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